DexCom
DXCM
#829
Rank
A$42.32 B
Marketcap
A$112.16
Share price
0.50%
Change (1 day)
4.15%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2026 (TTM): A$1.91 Billion

According to DexCom's latest financial reports the company's current earnings are A$4.96 Billion. In 2025 the company made an earning of A$1.57 Billion, an increase over its 2024 earnings that were of A$1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.91 B21.65%
2025 A$1.57 B52.02%
2024 A$1.03 B-0.37%
2023 A$1.03 B78.13%
2022 A$0.58 B47.34%
2021 A$0.39 B-10.11%
2020 A$0.43 B88.27%
2019 A$0.23 B-258.48%
2018 -A$0.15 Billion189.94%
2017 -A$50.86 Million-44.24%
2016 -A$91.21 Million12.43%
2015 -A$81.12 Million165.58%
2014 -A$30.55 Million-25.61%
2013 -A$41.06 Million-48.11%
2012 -A$79.13 Million24.5%
2011 -A$63.56 Million
2008 -A$75.05 Million13.18%
2007 -A$66.31 Million-5.36%
2006 -A$70.07 Million52.08%
2005 -A$46.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.23 B 1,923.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.55 B 528.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$10.41 B 465.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
A$2.12 B 15.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
A$1.98 B 7.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$86.66 Million-104.71%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-A$1.47 Billion-179.54%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
A$0.98 B-46.44%๐Ÿ‡บ๐Ÿ‡ธ USA